-
Imatinib hydrochloride: Reliable Assay Workflows
2026-09-21
Learn how Imatinib hydrochloride, SKU A3487, can support reproducible kinase-inhibition, viability, proliferation, and phosphosignaling experiments. This scenario-based guide separates biochemical potency from cell-level response, addresses DMSO handling and controls, and explains how to interpret target-specific data responsibly.
-
From RNA to Mechanism in HFpEF Research
2026-09-21
Translational HFpEF research depends on more than detecting a transcript: it requires a reproducible path from RNA template quality to mechanistic interpretation. This article examines how the TGFBR1 study frames that challenge and how the HyperScript™ First-Strand cDNA Synthesis Kit can support structured, low-abundance, and long-transcript workflows for PCR amplification and qPCR.
-
Ruxolitinib, DRP1, and ATC Cell Death
2026-09-20
The reference study identifies a JAK1/2–STAT3–DRP1 axis that links cytokine-associated signaling to mitochondrial fission and cell fate in anaplastic thyroid carcinoma. Its findings suggest that Ruxolitinib can promote caspase-dependent apoptosis and GSDME-mediated pyroptosis by transcriptionally suppressing DRP1, while also highlighting important limits for translating these results beyond ATC models.
-
γH2AX DNA Damage Detection Kit Workflow
2026-09-19
Translate radiation-induced DNA double-strand breaks into a spatially resolved red-foci readout with a practical γH2AX immunofluorescence workflow. The assay is especially useful for comparing FLASH-RT, conventional radiotherapy, radiosensitizers, apoptosis, and DNA repair kinetics in fixed cells or tissues.
-
GS967: Cardiac Late Sodium Current Studies
2026-09-18
This scenario-driven guide explains how GS967 (SKU B5850) can improve experimental consistency in cardiac late sodium current research without being misapplied as a general viability reagent. It connects formulation, concentration selection, controls, aging models, and arrhythmia endpoints to published electrophysiology findings.
-
HCAR3 Cryo-EM Structures Reveal Agonist Selectivity
2026-09-17
The 2025 PLOS Biology study combines cryo-EM structures and cellular cAMP assays to explain how HCAR3 recognizes agonists and distinguishes them from HCAR2. Its residue-level analysis clarifies the roles of orthosteric-pocket geometry and aromatic interactions, providing a framework for receptor-aware lipid metabolism research.
-
Dabigatran for Reliable Thrombin Assays
2026-09-17
Learn how Dabigatran, SKU A4077, can help researchers control thrombin-dependent variability in coagulation and cell-based workflows. This scenario-driven guide connects biochemical potency, assay compatibility, protocol design, interpretation, and practical product selection to evidence-backed laboratory decisions.
-
OsCPK4–OsCNGC7 Loop in Rice Salt Tolerance
2026-09-17
The reference study identifies an OsCPK4–OsCNGC7 phosphorylation-centered feedback loop that couples salt perception to Ca2+ influx in rice. Its time-dependent model explains how phosphorylation activates and stabilizes OsCNGC7 during early stress, while later attenuation helps balance defense with growth recovery.
-
Triamcinolone (B1859): Practical Research Workflow Guide
2026-09-16
Triamcinolone is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammatory responses, and immunosuppression. This guide addresses solvent selection, preparation, controls, storage, and troubleshooting; the compound is not intended for diagnostic, therapeutic, or clinical use.
-
Interpreting Anticancer Drug Responses In Vitro
2026-09-15
Hannah R. Schwartz’s dissertation separates growth inhibition from actual cell killing, showing that anticancer drugs can affect proliferation and death with different magnitudes and timing. This framework supports more informative viability studies by pairing relative and fractional viability with time-resolved and orthogonal cell-death measurements.
-
25-Hydroxycholesterol–AMPK Axis in TAMs
2026-09-15
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that activates lysosomal AMPKα through a GPR155–mTORC1 pathway in tumor-associated macrophages. The study connects this pathway to STAT6 phosphorylation, ARG1 production, macrophage immunosuppression, and improved anti-tumor responses after CH25H targeting, including in combination with anti-PD-1 therapy.
-
Zika Virus STAT2 Degron: Mechanism and Methods
2026-09-14
Parisien and colleagues identify the human STAT2 coiled-coil domain as both necessary and sufficient for Zika virus NS5 interaction and proteasome-dependent STAT2 loss. Their mapping of the first two coiled-coil alpha-helices defines a focused viral immune-evasion determinant and suggests a framework for testing host–virus protein interfaces.
-
Rottlerin: From PKCδ Mechanism to Translation
2026-09-14
Rottlerin offers translational researchers a valuable way to interrogate PKCδ-linked biology across proliferation, apoptosis, endothelial barrier function, and cellular entry. Its strongest value is not as a universal pathway switch, but as a mechanistic probe that can connect biochemical inhibition with time-resolved phenotypes. This article examines how to position Rottlerin as a PKC inhibitor, interpret its cancer and cell-entry evidence, manage selectivity and formulation constraints, and design experiments that remain credible when moving from discovery biology toward translational strategy.
-
JC-1 Mitochondrial Membrane Potential Assay
2026-09-13
The JC-1 Mitochondrial Membrane Potential Assay Kit reveals how mitochondrial depolarization contributes to treatment-induced cell death. This guide connects ratiometric ΔΨm measurement with mechanistic interpretation of hypoxia-activated cancer therapies.
-
Ciclesonide Workflows for Asthma Research
2026-09-12
Build more informative respiratory assays by separating Ciclesonide prodrug activation from the high-potency activity of desisobutyryl-ciclesonide. This workflow combines formulation control, bronchial-cell conversion studies, glucocorticoid receptor readouts, and carefully bounded lessons from emerging ERAD-based degradation research.